Results 21 to 30 of about 365,679 (259)

COVID-19 vaccine safety monitoring in Republic of Korea from February 26, 2021 to October 31, 2021 [PDF]

Osong Public Health and Research Perspectives, 2021
Objectives This study aimed to present data on reported adverse events following coronavirus disease 2019 (COVID-19) vaccination in Republic of Korea from February 26 to October 31, 2021, and to determine whether any significant patterns emerged from an ...
Insob Hwang, Kyeongeun Park, Tae Eun Kim, Yunhyung Kwon, Yeon-Kyeng Lee   +4 more
doaj   +1 more source

COVID-19 vaccine safety monitoring in the Republic of Korea: February 26, 2021 to April 30, 2021 [PDF]

Osong Public Health and Research Perspectives, 2021
Objectives On February 26, 2021, coronavirus disease 2019 (COVID-19) vaccination was started for high-priority groups based on the recommendation of the Advisory Committee on Immunization Practices with 2 available COVID-19 vaccines (AstraZeneca and ...
Hyun-kyung Oh, Eun Kyeong Kim, Insob Hwang, Tae Eun Kim, Yeon-kyeong Lee, Eunju Lee, Yeon-Kyeng Lee   +6 more
doaj   +1 more source

Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials

Respiratory Research, 2019
Background Given the broad definition of an acute exacerbation of IPF, it is likely that acute exacerbations are heterogeneous in their aetiology, severity and clinical course. We used pooled data from the INPULSIS® trials of nintedanib versus placebo to
Michael Kreuter, Harald Koegler, Matthias Trampisch, Silke Geier, Luca Richeldi   +4 more
doaj   +1 more source

Assessing the risk-benefit profile of ramucirumab in patients with advanced solid tumors: A meta-analysis of randomized controlled trials

EClinicalMedicine, 2020
Background: Ramucirumab is a widely used cancer drug having gained six regulatory approvals in various advanced solid tumors. Thus, assessing the risk-benefit profile of such a commonly used drug across multiple tumor types is necessary to inform ...
Sophie Marie Anne Effing, Bishal Gyawali
doaj   +1 more source

Vaccine confidence among those living with allergy during the COVID pandemic (ACCORD): A scoping review

Journal of Allergy and Clinical Immunology: Global, 2023
Background: Reports of allergic reactions to coronavirus disease 2019 (COVID-19) vaccines, coupled with an “infodemic” of misinformation, carry the potential to undermine confidence in the COVID-19 vaccines.
Ayel Luis R. Batac, Kaitlyn A. Merrill, BSc (Hons), Nicole Askin, MLIS, Michael A. Golding, MA, Elissa M. Abrams, MD, MPH, FRCPC, Philippe Bégin, MD, PhD, FRCPC, Moshe Ben-Shoshan, MD, MSc, Erika Ladouceur, Leslie E. Roos, PhD, Vladan Protudjer, RN, BN, MMed, Jennifer L.P. Protudjer, PhD   +10 more
doaj   +1 more source

Exploring procedure duration and risk for serious adverse events during congenital cardiac catheterization

BMJ Surgery, Interventions, & Health Technologies, 2023
Objectives While procedure length is considered an important metric for cardiothoracic surgical procedures, the relationship between procedure length and adverse events (AEs) in congenital cardiac catheterizations has little published data available ...
Lisa Bergersen, Kimberlee Gauvreau, Kathy J Jenkins, David Slater, Mary J Yeh, Elizabeth Lydon   +5 more
doaj   +1 more source

Adverse events in total knee arthroplasty: Results of a physician independent survey in 260 patients

Patient Safety in Surgery, 2010
Purpose Identification of all common and potentially avoidable adverse events is crucial to further improve the quality of medical care. The intention of the current study was to evaluate a standardized physician independent survey format on adverse ...
Kirschner Stephan, Lützner Jörg, Günther Klaus-Peter, Eberlein-Gonska Maria, Krummenauer Frank   +4 more
doaj   +1 more source

Safety Assessment of Conventional and Biological Systemic Therapy in Older Adults with Psoriasis, a Real-world Multicentre Cohort Study

Acta Dermato-Venereologica, 2022
Optimal selection of systemic therapy in older adults with psoriasis can be challenging, due to sparse evidence-based guidance. This multicentre retrospective study investigated the safety of systemic therapy with causality assessment in a real-world ...
Elke L.M. ter Haar, Eline E. ten Bruin, Ewald E. Bronkhorst, Rinke J. Borgonjen, Marloes M. Kleinpenning, Else N. Kop, M. Birgitte Visch, Peter C.M. van de Kerkhof , Elke M.G.J. de Jong , Satish F.K. Lubeek   +9 more
doaj   +1 more source

Serious adverse events after cataract surgery [PDF]

Current Opinion in Ophthalmology, 2012
Over the past several decades, there have been many advances in the equipment, instrumentation and techniques of performing cataract surgery. This review will address the impact of these advances on the safety profile of cataract surgery.Recent studies have demonstrated a decline in the risk of serious postoperative adverse events (endophthalmitis ...
openaire   +2 more sources

Sustained Therapeutic Efficacy of Intravenous Plasminogen Concentrate in Pediatric Patients With Type 1 Plasminogen Deficiency: An Analysis of Dosing Parameters and Clinical Outcomes

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Type 1 plasminogen deficiency (PLGD‐1) is an ultra‐rare autosomal recessive disorder caused by variants in the PLG gene and affects approximately 1.6 individuals per million. The condition is characterized by decreased plasminogen levels and impaired function, resulting in fibrin‐rich lesions on mucous membranes throughout the body.
Charles Nakar, Karen Thibaudeau, Mary Mathias, Heather McDaniel, Madlen Reschke, Klaus Tenbrock, Joseph M. Parker, Amy Shapiro   +7 more
wiley   +1 more source